KAPLAN et al., 1977 - Google Patents
Changes in serum 3, 3′, 5′-triiodothyronine (reverse T3) concentrations with altered thyroid hormone secretion and metabolismKAPLAN et al., 1977
- Document ID
- 11709690185739978706
- Author
- KAPLAN M
- SCHIMMEL M
- UTIGER R
- Publication year
- Publication venue
- The Journal of Clinical Endocrinology & Metabolism
External Links
Snippet
A sensitive radioimmunoassay was developed for measurement of 3, 3′, 5′- triiodothyronine (rT3) in unextracted serum using 8-anilinonaphthalene-6-sulfonic acid (ANS) to inhibit binding of rT3 to serum proteins. Normal serum r⊂ concentrations were …
- 210000002966 Serum 0 title abstract description 181
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KAPLAN et al. | Changes in serum 3, 3′, 5′-triiodothyronine (reverse T3) concentrations with altered thyroid hormone secretion and metabolism | |
| Amino et al. | Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis | |
| Schambelan et al. | Mineralocorticoid production in hyperadrenocorticism: Role in pathogenesis of hypokalemic alkalosis | |
| Liewendahl et al. | Thyroid function tests in patients on long‐term treatment with various anticonvulsant drugs | |
| Goebelsmann et al. | Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration | |
| HIGGINS et al. | The thyrotoxicosis of hydatidiform mole | |
| Hall et al. | Radioimmunoassay of human serum thyrotrophin | |
| BURMAN et al. | Ionized and total serum calcium and parathyroid hormone in hyperthyroidism | |
| Beierwaltes et al. | Familial increase in the thyroxine-binding sites in serum alpha globulin | |
| Bray et al. | Relation of thyroid hormones to body-weight | |
| RAPOPORT et al. | Suppression of serum thyrotropin (TSH) by L-dopa in chronic hypothyroidism: interrelationships in the regulation of TSH and prolactin secretion | |
| DOWLING et al. | Iodine metabolism in hydatidiform mole and choriocarcinoma | |
| Yen et al. | Hormonal relationships during the menstrual cycle | |
| Tanaka et al. | Clinical observations on serum globulin thyroxine-binding capacity, using a simplified technique | |
| Cohen et al. | Determinants of thyroxine-induced cardiac hypertrophy in mice | |
| Ingbar et al. | Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves' disease | |
| WEEKE et al. | Diurnal TSH variations in hypothyroidism | |
| ROSE et al. | Circadian variation of thyrotropin in childhood | |
| Hamon et al. | Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy | |
| Liewendahl et al. | Thyroxine, triiodothyronine, and thyrotropin in serum during long-term diphenylhydantoin therapy | |
| Cooper et al. | Familial thyroid hormone resistance | |
| Braverman et al. | Thyroid hormone transport in the serum of patients with thyrotoxic Graves' disease before and after treatment | |
| FABER et al. | Measurements of serum 3′, 5′-diiodothyronine and 3, 3′-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: studies of 3′, 5′-diiodothyronine metabolism | |
| Aanderud et al. | The influence of carbamazepine on thyroid hormones and thyroxine binding globulin in hypothyroid patients substituted with thyroxine | |
| MEINHOLD et al. | Circulating diiodotyrosine: studies of its serum concentration, source, and turnover using radioimmunoassay after immunoextraction |